Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer

Özet

Açıklama

Anahtar kelimeler

Alıntı

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By